Clinical and pharmacological aspects of the use of drugs for COVID-19 in pregnant women


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

There is limited experience with the use of medicines to treat COVID-19 in women during pregnancy and breastfeeding. The use of a number of drugs during these periods is absolutely contraindicated. The use of other medications is possible with a balanced assessment of the relative risk and benefit. When using medicines, a pregnant and lactation women must follow the instructions for a specific drug.

全文:

受限制的访问

作者简介

V. Tsvetov

Federal Center for Cardiovascular Surgery

Chelyabinsk, Russia

K. Mirzaev

Russian Medical Academy of Continuous Professional Education

Moscow, Russia

参考

  1. Методические рекомендации. Организация оказания медицинской помощи беременным, роженицам, родильницам и новорожденным при новой коронавирусной инфекции COVID-19. М.: Министерство здравоохранения Российской Федерации, 2020. 66 c
  2. Poon L.C, Yang H., Lee J.C., et al. ISUOG Interim Guidance on 2019 novel coronavirus infection during pregnancy and puerperium: information for healthcare professionals. Ultrasound Obstet Gynecol. 2020. Doi: 10.1002/ uog.22013.
  3. Временные методические рекомендации. Профилактика, диагностика и лечение новой коронавирусной инфекции (COVID-19). Версия 8.1 (01.10.2020). М.: Министерство здравоохранения Российской Федерации, 2020. 226 c
  4. Государственный реестр лекарственных средств (Электронный ресурс). [State register of medicines (Electronic resource). (In Russ.)]. URL: https://grls.rosminzdrav.ru
  5. The electronic medicines compendium (EMC) [Electronic resource]. URL: https://www. medicines.org.uk/emc/
  6. An Australian categorisation of risk of drug use in pregnancy [Electronic resource]. URL: https:// www.tga.gov.au/prescribing-medicines-pregnancy-database

补充文件

附件文件
动作
1. JATS XML

版权所有 © Bionika Media, 2020